ArticleLaryngoscope investigative otolaryngology2026
Smoking Status and Recurrence in Oral Tongue Squamous Cell Carcinoma: Evidence for Convergent Clinical Behavior.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Oral tongue squamous cell carcinomas (SCCOT) arising in never-smokers and smokers have similar genomic profiles, suggesting tobacco exposure may not be the dominant driver of tumor biology at this site. We investigated whether smoking is related to recurrence risk in SCCOT. Methods: We analyzed disease-free survival (DFS) in two SCCOT cohorts: a discovery cohort of 86 patients and a validation cohort of 410 patients, both treated and followed at MD Anderson Cancer Center with available smoking histories and demographic, clinical, and pathologic information. The initial validation cohort included 424 patients; however, 14 patients overlapping with the discovery cohort were excluded to preserve cohort independence. The risk of recurrence was assessed using univariate and multivariable Cox regression models adjusted for prognostic factors. Smoking was evaluated as ever-smoker versus never-smoker and as high versus low cumulative exposure (> 15 vs. ≤ 15 pack-years). Results: In the discovery cohort, no statistically significant differences in DFS were observed by smoking status (log-rank Conclusion: These findings suggest smoking history was not independently associated with recurrence risk in SCCOT. Larger prospective studies are required to validate these findings. Further studies integrating genomic and transcriptomic profiling are needed to define high-risk SCCOT biology and identify biomarkers for personalized treatment. Impact: By demonstrating smoking status does not influence recurrence risk, our findings provide clinical support for prior genomic evidence of similarity between SCCOT in smokers and never-smokers, arguing against the use of smoking history to define prognostic subgroups. Level of Evidence: 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.